Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05465629 · ClinicalTrials.gov registry record · NA
Viome Nutritional Programs to Improve Clinical Outcomes for Gastrointestinal Conditions
A NA study of Gastrointestinal Health, sponsored by Viome.
- Recruiting
- Registry status
- NA
- Development phase
- 150
- Enrollment target
- 1
- Study location
NCT05465629: Recruiting NA study of Gastrointestinal Health, sponsored by Viome.
NCT05465629 is a NA study of Gastrointestinal Health that is actively recruiting participants, run by Viome. The registered enrollment target is 150 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (89% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05465629, a NA study of Gastrointestinal Health, is actively recruiting participants, sponsored by Viome.
- RECRUITING
- Registry status
- NA
- Development phase
- 150 participants
- Enrollment target
- 1
- Study location
Study Summary
US residents who have gastrointestinal issues sign the informed consent form and are screened and enrolled for this study. Participants who are enrolled complete a survey upon enrollment and are randomized into one of three arms. This study is direct to participant and will NOT utilize clinical sites.
Primary Outcome
Number of participants that show an improvement in GI health compared to baseline survey assessment.
Conditions Studied
Interventions
- COMBINATION_PRODUCT VIOME Precision Nutrition Program
- DIETARY_SUPPLEMENT VIOME-designed condition-based supplements
Study Locations (1)
Washington
- Viome Life Sciences - Bothell
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2022-11-18 |
| Est. Completion | 2026-12 |
| Phase | NA |
What NCT05465629 shows while recruiting
NCT05465629 is an interventional study that assigns participants to a tested intervention. The registered 150 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (89% lower).
The record links to 1 condition, with Gastrointestinal Health appearing as the primary indexed condition, and to 2 interventions - of which VIOME Precision Nutrition Program is the first listed.
NCT05465629 reports a single indexed study location in Washington.
Frequently Asked Questions
What is clinical trial NCT05465629 about?
NCT05465629 is a clinical study titled "Viome Nutritional Programs to Improve Clinical Outcomes for Gastrointestinal Conditions". US residents who have gastrointestinal issues sign the informed consent form and are screened and enrolled for this study. Participants who are enrolled complete a survey upon enrollment and are randomized into one of three arms. This study is direct to participant and will NOT utilize clinical site...
What is the current status of trial NCT05465629?
This trial is currently recruiting. It is a NA study. The enrollment target is 150 participants. The study started on 2022-11-18. Estimated completion is 2026-12.
What conditions does trial NCT05465629 study?
This clinical trial studies the following conditions: Gastrointestinal Health.
What interventions are being tested in trial NCT05465629?
The interventions under investigation include: VIOME Precision Nutrition Program (COMBINATION_PRODUCT), VIOME-designed condition-based supplements (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT05465629?
This trial is sponsored by Viome, which has 18 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05465629 being conducted?
This trial has 1 study location across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Gastrointestinal Health
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05465629's enrollment target sits among peer trials
150 661st of 2000 higher than 1,299 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00412594 · 150 participants · Phase 2
Cladribine and Rituximab in Treating Patients With Hairy Cell Leukemia
- NCT01484730 · 150 participants
A Pilot Study to Evaluate Multi-Spectral and Laser Speckle Imaging and Multiphoton Microscopy During Vascular Occlusion
- NCT01985919 · 150 participants
Protocol for Facilitating the Acquisition of Research Bone Marrow and Blood Samples
- NCT02016248 · 150 participants · NA
SBRT Boost for Unfavorable Prostate Cancer'
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI